Mounjaro, a relatively novel drug approved by the FDA in May 2023, is generating significant interest within the medical community for its potential to treat Type 2 diabetes. While not a cure, Mounjaro appears to be providing substantial benefits in managing blood sugar levels and reducing the need for other medications. Early studies show promisin